United States - Construction New Scientific Computational Facility

Description

Added: Jun 06, 2019 8:33 am

MARKET RESEARCH PURPOSES ONLY
NOT A REQUEST FOR PROPOSAL OR SOLICITATION

The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grants Services (OAGS) is conducting market research to support the National Center for Toxological Research (NCTR) requirement for Bldg. 18 - Scientific Computational Facility.
This is a Sources Sought notice to determine the availability and capability of small businesses to provide construction for Building 18- Scientific Computational Facility, Phase I. This notice is for planning purposes only, and does not constitute an invitation for Bids, Request for Proposal or Request for Quotation or an indication the Government to award a contract, nor does the Government intend to pay for any information submitted as a result of this notice. Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible.
The appropriate NAICS code for the acquisition is 236220 -- Commercial and Institutional Building Construction; Small Business Size standards $36.5 MIL.
Statement of Need:
The U.S. Food and Drug Administration (FDA), Jefferson Laboratories requires the construction of a new building (Building 18 - Scientific Computational Facility (SCF), Phase 1) located at Jefferson, Arkansas.
This requirement will consist of furnishing all labor, equipment, materials, and transportation for the construction of a new facility, Bldg. 18 - Scientific Computational Facility (SCF), Phase 1), which is approximately 10,000 square feet single story building consisting of a data center, offices and support spaces.

The project magnitude is between $5 million and $10 million.
Place of Performance:
U.S. Food and Drug Administration
National Center for Toxicological Research
3900 NCTR Road, Bldg.
Jefferson, AR 72079
Responses to this sources sought shall unequivocally demonstrate the respondent is regularly engaged in providing facility construction. Though the target audience is small businesses capable of providing facility construction, all interested parties may respond. At a minimum, responses shall include the following:
1. Business name and bio, DUNS number, business address, business website, business size status (i.e., SB, VOSB, SDVOSB, HUBZone SB, SDB, WOSB, LB), point of contact name, mailing address (if different from business address), phone number and email address. Provide this same information again if responding to provide a service offered by another firm.
2. Firms believing, they can meet the requirements above shall furnish capability statements sufficiently detailed for the Government to conclusively determine the experience and qualifications of the firm for the above project. Respondents shall limit their capability statements to no more than ten (10) pages, excluding cover page and table of contents. At a minimum, responses shall include the following:
a. Cover page shall include, at a minimum, Business name, DUNS number, business address, business website, business size status (i.e., SB, VOSB, SDVOSB, HUBZone SB, SDB, WOSB, LB), point of contact name, mailing address (if different from business address), phone number and email address.
b. Capability statements must provide detailed references and experience similar to the work described above performed by the contractor in the last three (3) years. For each prior experience reference provide description of work, contract value, customer name and point of contact, customer address, customer telephone number, and any other information to demonstrate qualifications. Clearly delineate the firm's role and responsibilities of the referenced contracts such as prime contractor, party to joint venture, subcontractor, etc.
c. Capability statement shall provide proof of bonding capability (note magnitude of construction project above).
3. If applicable, identification of the firm's GSA Schedule contract(s) by Schedule number and SINs that are applicable to this potential requirement are also requested. If a large business, provide if subcontracting opportunities exist for small business concerns. The Government is not responsible for locating or securing any information, not identified in the response.
Interested parties shall respond with capability statements in person, by e-mail, fax, mail or other delivery method before 1:00 pm (Central Standard Time - Local Prevailing Time in Jefferson, Arkansas) on June 21, 2019 to howard.nesmith@fda.hhs.gov, Fax to (870) 543-7459, or mail to the U. S. Food and Drug Administration, OO/OFBA/OAGS/DAP, Attention of Howard Nesmith, 3900 NCTR Road, Building 50, Room 424, Jefferson, AR 72079-9502 and Reference: FDA1211794.
Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre‐solicitation synopsis and solicitation may be published in Federal Business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation.
Confidentiality: No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non‐proprietary technical information in any resultant solicitation(s).

Opportunity closing date

21 June 2019

Value of contract

to be confirmed